Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6713)
All Articles published online
|
Publishing Process of This Article
|
Oct 7, 2013 (publication date) through Dec 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | de Mello RA, Marques AM, Araújo A. HER2 therapies and gastric cancer: A step forward. World J Gastroenterol 2013; 19(37): 6165-6169 [PMID: 24115812 DOI: 10.3748/wjg.v19.i37.6165] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i37/6165.htm |
| Number | Citing Articles |
| 1 |
Ramon Andrade De Mello, Luis Castelo-Branco, Pedro Castelo-Branco, Daniel Humberto Pozza, Louis Vermeulen, Sofia Palacio, Matthew Salzberg, A. Craig Lockhart. What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies?. American Society of Clinical Oncology Educational Book 2018; (38): 249 doi: 10.1200/EDBK_198805
|
| 2 |
Francesca Sanguedolce, Pantaleo Bufo. HER2 assessment by silverin situhybridization: where are we now?. Expert Review of Molecular Diagnostics 2015; 15(3): 385 doi: 10.1586/14737159.2015.992416
|
| 3 |
Chen Yun, Li Gang, Gu Rongmin, Wen Xu, Ming Xuezhi, Chen Huanqiu. Essential role of Her3 in two signaling transduction patterns: Her2/Her3 and MET/Her3 in proliferation of human gastric cancer. Molecular Carcinogenesis 2015; 54(12): 1700 doi: 10.1002/mc.22241
|
| 4 |
Kinisha Gala, Sarat Chandarlapaty. Molecular Pathways: HER3 Targeted Therapy. Clinical Cancer Research 2014; 20(6): 1410 doi: 10.1158/1078-0432.CCR-13-1549
|
| 5 |
Yin Zhu, Yi Hu, Ming Cheng, Chun-Yan Zeng, Zhen Yang, Xiao-Dong Zhou, Jiang Chen, Nong-Hua Lu. Establishment and Characterization of a Nude Mouse Model of Subcutaneously Implanted Tumors and Abdominal Metastasis in Gastric Cancer. Gastroenterology Research and Practice 2017; 2017: 1 doi: 10.1155/2017/6856107
|
| 6 |
Yoko Murayama, Kenji Oritani, Shusaku Tsutsui. Novel CD9-targeted therapies in gastric cancer. World Journal of Gastroenterology 2015; 21(11): 3206-3213 doi: 10.3748/wjg.v21.i11.3206
|
| 7 |
Byungho Lim, Jong-Hwan Kim, Mirang Kim, Seon-Young Kim. Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer. World Journal of Gastroenterology 2016; 22(3): 1190-1201 doi: 10.3748/wjg.v22.i3.1190
|
| 8 |
Michaela Aichler, Birgit Luber, Florian Lordick, Axel Walch. Proteomic and metabolic prediction of response to therapy in gastric cancer. World Journal of Gastroenterology 2014; 20(38): 13648-13657 doi: 10.3748/wjg.v20.i38.13648
|
| 9 |
Zhen Zeng, Yating Fu, Dongyang Guo, Yuxuan Wu, Olugbenga Emmanuel Ajayi, Qingfa Wu. Bacterial endosymbiont Cardinium cSfur genome sequence provides insights for understanding the symbiotic relationship in Sogatella furcifera host. BMC Genomics 2018; 19(1) doi: 10.1186/s12864-018-5078-y
|
| 10 |
Tae-Lim Kim, Man-Ho Cho, Kanidta Sangsawang, Seong Hee Bhoo. Fine Mutational Analysis of 2B8 and 3H7 Tag Epitopes with Corresponding Specific Monoclonal Antibodies. Molecules and Cells 2016; 39(6): 460 doi: 10.14348/molcells.2016.2265
|
| 11 |
Giandomenico Roviello, Andrea Ravelli, Anna Ida Fiaschi, Maria Rosa Cappelletti, Angela Gobbi, Chiara Senti, Laura Zanotti, Karol Polom, Andrew R. Reynolds, Stephen B. Fox, Daniele Generali. Apatinib for the treatment of gastric cancer. Expert Review of Gastroenterology & Hepatology 2016; : 1 doi: 10.1080/17474124.2016.1209407
|
| 12 |
Hans H. Oberg, Christian Kellner, Daniel Gonnermann, Susanne Sebens, Dirk Bauerschlag, Martin Gramatzki, Dieter Kabelitz, Matthias Peipp, Daniela Wesch. Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00814
|
| 13 |
Deniz Arslan, Mukremin Uysal, Ali Murat Tatlı, Seyda Gunduz, Sema Sezgin Goksu, Cumhur İbrahim Başsorgun, Hasan Senol Coskun, Hakan Bozcuk, Burhan Savaş. Her-2 Positive Gastric Cancer Presented with Thrombocytopenia and Skin Involvement: A Case Report. Case Reports in Oncological Medicine 2014; 2014: 1 doi: 10.1155/2014/194636
|
| 14 |
Juliane M. Jürgensmeier, Joseph P. Eder, Roy S. Herbst. New Strategies in Personalized Medicine for Solid Tumors: Molecular Markers and Clinical Trial Designs. Clinical Cancer Research 2014; 20(17): 4425 doi: 10.1158/1078-0432.CCR-13-0753
|
| 15 |
Emmy D.G. Fleuren, Yvonne M.H. Versleijen-Jonkers, Sandra Heskamp, Carla M.L. van Herpen, Wim J.G. Oyen, Winette T.A. van der Graaf, Otto C. Boerman. Theranostic applications of antibodies in oncology. Molecular Oncology 2014; 8(4): 799 doi: 10.1016/j.molonc.2014.03.010
|
| 16 |
Kelly M Mahuron, Kevin M Sullivan, Matthew C Hernandez, Yi-Jen Chen, Joseph Chao, Laleh G Melstrom, I. Benjamin Paz, Jae Yul Kim, Rifat Mannan, James L. Lin, Yuman Fong, Yanghee Woo. Diffuse-Type Histology Is Prognostic for All Siewert Types of Gastroesophageal Adenocarcinoma. Journal of Gastric Cancer 2024; 24(3): 267 doi: 10.5230/jgc.2024.24.e20
|
| 17 |
Gianluca Petris, Marco Bestagno, Francesca Arnoldi, Oscar R. Burrone, Nicholas J. Mantis. New Tags for Recombinant Protein Detection and O-Glycosylation Reporters. PLoS ONE 2014; 9(5): e96700 doi: 10.1371/journal.pone.0096700
|
| 18 |
Zhi-fang Jia, Song-ling Zhang, Xue-yuan Cao, Bao-sen Zhou, Jing Jiang.
Interaction Between
Helicobacter Pylori
and Host Genetic Variants in Gastric Carcinogenesis
. Future Oncology 2016; 12(18): 2127 doi: 10.2217/fon-2016-0233
|
| 19 |
Luigi Marano, Rita Chiari, Alessio Fabozzi, Ferdinando De Vita, Virginia Boccardi, Giandomenico Roviello, Roberto Petrioli, Daniele Marrelli, Franco Roviello, Alberto Patriti. c-Met targeting in advanced gastric cancer: An open challenge. Cancer Letters 2015; 365(1): 30 doi: 10.1016/j.canlet.2015.05.028
|
| 20 |
Tianwei Zhang, Lin Zhang, Shuqiong Fan, Meizhuo Zhang, Haihua Fu, Yuanjie Liu, Xiaolu Yin, Hao Chen, Liang Xie, Jingchuan Zhang, Paul R. Gavine, Yi Gu, Xingzhi Ni, Xinying Su, Eric Asselin. Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully Represent Human Tumor Molecular Diversity. PLOS ONE 2015; 10(7): e0134493 doi: 10.1371/journal.pone.0134493
|
| 21 |
Ramon Andrade de Mello, Jailson de Oliveira, Georgios Antoniou. Angiogenesis and Apatinib: A New Hope for Patients with Advanced Gastric Cancer?. Future Oncology 2017; 13(4): 295 doi: 10.2217/fon-2016-0318
|
| 22 |
Changyuan Hu, Jiangning Song, Terry Kwok, Elizabeth V. Nguyen, Xian Shen, Roger J. Daly. Proteome‐based molecular subtyping and therapeutic target prediction in gastric cancer. Molecular Oncology 2024; 18(6): 1437 doi: 10.1002/1878-0261.13654
|
| 23 |
Ramon Andrade De Mello, Florian Lordick, Kei Muro, Yelena Y. Janjigian. Current and Future Aspects of Immunotherapy for Esophageal and Gastric Malignancies. American Society of Clinical Oncology Educational Book 2019; (39): 237 doi: 10.1200/EDBK_236699
|
| 24 |
Giandomenico Roviello, Roberto Petrioli, Luigi Marano, Karol Polom, Daniele Marrelli, Armando Perrella, Franco Roviello. Angiogenesis inhibitors in gastric and gastroesophageal junction cancer. Gastric Cancer 2016; 19(1): 31 doi: 10.1007/s10120-015-0537-5
|
| 25 |
Shanshan Nie, Guoping Yang, Hongwei Lu. <p>Current Molecular Targeted Agents for Advanced Gastric Cancer</p>. OncoTargets and Therapy 2020; : 4075 doi: 10.2147/OTT.S246412
|
| 26 |
Karol Polom, Luigi Marano, Giandomenico Roviello, Roberto Petrioli, Riccardo Piagnerelli, Lorenzo de Franco, Daniele Marrelli, Franco Roviello. Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence. International Journal of Hyperthermia 2016; 32(2): 173 doi: 10.3109/02656736.2015.1111432
|
| 27 |
Marina V. Nemtsova, Ekaterina B. Kuznetsova, Irina V. Bure. Chromosomal Instability in Gastric Cancer: Role in Tumor Development, Progression, and Therapy. International Journal of Molecular Sciences 2023; 24(23): 16961 doi: 10.3390/ijms242316961
|
| 28 |
Giandomenico Roviello, Karol Polom, Roberto Petrioli, Luigi Marano, Daniele Marrelli, Giovanni Paganini, Vinno Savelli, Daniele Generali, Lorenzo De Franco, Andrea Ravelli, Franco Roviello. Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives. Tumor Biology 2016; 37(1): 127 doi: 10.1007/s13277-015-4408-9
|
| 29 |
Gaetano Romano. Tumor markers currently utilized in cancer care. Materials and Methods 2015; 5 doi: 10.13070/mm.en.5.1456
|
| 30 |
Jing Shi, Yi-Ping Qu, Peng Hou. Pathogenetic mechanisms in gastric cancer. World Journal of Gastroenterology 2014; 20(38): 13804-13819 doi: 10.3748/wjg.v20.i38.13804
|
| 31 |
Ramon Andrade De Mello. Gastric Cancer in Southern Europe: High-Risk Disease. American Society of Clinical Oncology Educational Book 2017; (37): 261 doi: 10.1200/EDBK_175227
|
| 32 |
Giandomenico Roviello, Andrea Ravelli, Karol Polom, Roberto Petrioli, Luigi Marano, Daniele Marrelli, Franco Roviello, Daniele Generali. Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer. Cancer Letters 2016; 372(2): 187 doi: 10.1016/j.canlet.2016.01.014
|
| 33 |
James Kalmuk, Dan Rinder, Carl Heltzel, Albert Craig Lockhart. An overview of the preclinical discovery and development of trastuzumab deruxtecan: a novel gastric cancer therapeutic. Expert Opinion on Drug Discovery 2022; 17(5): 427 doi: 10.1080/17460441.2022.2050692
|
| 34 |
Eva Andreuzzi, Albina Fejza, Alessandra Capuano, Evelina Poletto, Eliana Pivetta, Roberto Doliana, Rosanna Pellicani, Andrea Favero, Stefania Maiero, Mara Fornasarig, Renato Cannizzaro, Renato V. Iozzo, Paola Spessotto, Maurizio Mongiat. Deregulated expression of Elastin Microfibril Interfacer 2 (EMILIN2) in gastric cancer affects tumor growth and angiogenesis. Matrix Biology Plus 2020; : 100029 doi: 10.1016/j.mbplus.2020.100029
|
| 35 |
Eva Andreuzzi, Alessandra Capuano, Rosanna Pellicani, Evelina Poletto, Roberto Doliana, Stefania Maiero, Mara Fornasarig, Raffaella Magris, Alfonso Colombatti, Renato Cannizzaro, Paola Spessotto, Maurizio Mongiat. Loss of Multimerin-2 and EMILIN-2 Expression in Gastric Cancer Associate with Altered Angiogenesis. International Journal of Molecular Sciences 2018; 19(12): 3983 doi: 10.3390/ijms19123983
|
| 36 |
Jian-Xian Lin, Yan-Chang Xu, Wei Lin, Fang-Qin Xue, Jian-Xin Ye, Wei-Dong Zang, Li-Sheng Cai, Jun You, Jian-Hua Xu, Jian-Chun Cai, Yi-Hui Tang, Jian-Wei Xie, Ping Li, Chao-Hui Zheng, Chang-Ming Huang. Effectiveness and Safety of Apatinib Plus Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer. JAMA Network Open 2021; 4(7): e2116240 doi: 10.1001/jamanetworkopen.2021.16240
|
| 37 |
J. S. Sukanya, Pavithra Vittal Raj, J. Thanka. Role of HER2neu expression in gastric cancer. Indian Journal of Pathology and Microbiology 2021; 64(1): 58 doi: 10.4103/IJPM.IJPM_835_19
|